Dr. Oscar H Salvat, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2251 W Elm St, Wrightsville, GA 31096 Phone: 478-864-3448 Fax: 478-864-1288 |
Mr. Anthony Lewis Howard Sr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2251 W Elm St, Wrightsville, GA 31096 Phone: 478-864-3448 Fax: 478-864-1288 |
Dr. Mary S.e. Alston, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Donovan Harrison Road, Medical Department, Wrightsville, GA 31096 Phone: 478-864-4973 Fax: 478-864-4274 |
Mr. Robert Daniel Shuman Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2257 West Elm Street, Suite C, Wrightsville, GA 31096 Phone: 478-864-0032 Fax: 478-864-1220 |
News Archive
In the study, which appeared on the pre-print open-source medRxiv* server, the investigators aimed to determine the prognostic value of blood glucose in predicting outcomes in COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
White-tailed deer have been observed to be susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They can also transmit the virus both through direct and indirect contact to one another, researchers find. The research paper is available to be read online in the Journal of Virology.
On March 4, SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWestâ„¢ Total Artificial Heart, announced that its new Freedomâ„¢ driver system has received the CE Mark to power the Total Artificial Heart in Europe.
Those who accept their pain condition are best able to tolerate pain, while distraction can be the way to lower pain intensity, according to research reported in The Journal of Pain, the peer review publication of the American Pain Society.
When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.
› Verified 2 days ago